{
     "PMID": "10745080",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20000504",
     "LR": "20161124",
     "IS": "0014-5793 (Print) 0014-5793 (Linking)",
     "VI": "470",
     "IP": "3",
     "DP": "2000 Mar 31",
     "TI": "Activation of a capacitative Ca(2+) entry pathway by store depletion in cultured hippocampal neurones.",
     "PG": "269-72",
     "AB": "Intracellular Ca(2+) ([Ca(2+)](i)) changes were measured in cell bodies of cultured rat hippocampal neurones with the fluorescent indicator Fluo-3. In the absence of external Ca(2+), the cholinergic agonist carbachol (200 microM) and the sarcoendoplasmic reticulum Ca(2+) pump inhibitor thapsigargin (0.4 microM) both transiently elevated [Ca(2+)](i). A subsequent addition of Ca(2+) into the bathing medium caused a second [Ca(2+)](i) change which was blocked by lanthanum (50 microM). Taken together, these experiments indicate that stores depletion can activate a capacitative Ca(2+) entry pathway in cultured hippocampal neurones and further demonstrate the existence of such a Ca(2+) entry in excitable cells.",
     "FAU": [
          "Bouron, A"
     ],
     "AU": [
          "Bouron A"
     ],
     "AD": "Department of Pharmacology, University of Bern, Friedbuehlstrasse 49, Bern, Switzerland. alexandre.bouron@pcs.u-bordeaux2.fr",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "PL": "England",
     "TA": "FEBS Lett",
     "JT": "FEBS letters",
     "JID": "0155157",
     "RN": [
          "0 (Aniline Compounds)",
          "0 (Cholinergic Agonists)",
          "0 (Excitatory Amino Acid Antagonists)",
          "0 (Xanthenes)",
          "23D4W0B50Y (Fluo-3)",
          "4368-28-9 (Tetrodotoxin)",
          "67526-95-8 (Thapsigargin)",
          "6I3K30563S (Lanthanum)",
          "6OTE87SCCW (6-Cyano-7-nitroquinoxaline-2,3-dione)",
          "8Y164V895Y (Carbachol)",
          "EC 3.6.3.8 (Calcium-Transporting ATPases)",
          "RWP5GA015D (Potassium)",
          "SY7Q814VUP (Calcium)"
     ],
     "SB": "IM",
     "MH": [
          "6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology",
          "Aniline Compounds/metabolism",
          "Animals",
          "Calcium/*metabolism/pharmacology",
          "Calcium Signaling/drug effects",
          "Calcium-Transporting ATPases/antagonists & inhibitors/metabolism",
          "Carbachol/pharmacology",
          "Cells, Cultured",
          "Cholinergic Agonists/pharmacology",
          "Electric Conductivity",
          "Excitatory Amino Acid Antagonists/pharmacology",
          "Hippocampus/*cytology/metabolism",
          "Lanthanum/pharmacology",
          "Neurons/drug effects/*metabolism",
          "Potassium/pharmacology",
          "Rats",
          "Tetrodotoxin/pharmacology",
          "Thapsigargin/pharmacology",
          "Xanthenes/metabolism"
     ],
     "EDAT": "2000/04/04 09:00",
     "MHDA": "2000/05/08 09:00",
     "CRDT": [
          "2000/04/04 09:00"
     ],
     "PHST": [
          "2000/04/04 09:00 [pubmed]",
          "2000/05/08 09:00 [medline]",
          "2000/04/04 09:00 [entrez]"
     ],
     "AID": [
          "S0014-5793(00)01340-5 [pii]"
     ],
     "PST": "ppublish",
     "SO": "FEBS Lett. 2000 Mar 31;470(3):269-72.",
     "term": "hippocampus"
}